Preclinical CRO Market Size, Share & Trends Analysis Report By Service, By End Use And Segment Forecasts From 2022 To 2030

Report ID: MN17620359  |  Published: October 2022  |  No of Pages: 275
Format: Electronic (PDF)  |  Industry: Medical Devices

The global preclinical CRO market size was valued at USD 4.87 billion in 2021 and is projected to reach USD 9.67 billion by 2030, expanding at a CAGR of 7.9%. The growth in outsourcing opportunities for preclinical CRO services, in addition to early research activities during the drug discovery process, are two major factors primarily determining the market preclinical CRO market growth. The market is also predicted to witness profitable growth in the forthcoming years.

The development and introduction of new drugs entering the preclinical phase are expected to boost market growth during the forecast years. The COVID-19 pandemic had a negative impact on the preclinical CRO market for a temporary period due to the implementation of a worldwide lockdown that led to a shutdown of the research sites and new trials put to hold. However, lifesaving drugs are being developed and brought to the market at a swift pace currently.

The ever-ascending prevalence of chronic diseases, especially among the geriatric population is a key factor influencing organizations to invest more in this industry and develop drugs for the prevention of such diseases. Since the pandemic, major pharmaceutical and biopharmaceutical companies have continued to invest in the development of novel drugs and devices along with increasing their R&D efficiencies. A wide range of organizations around the globe have made significant investments and funding for developing medical devices and therapeutics for COVID-19.

The market is undergoing several remarkable expansions with a series of mergers and acquisitions resulting in better international reach of larger companies, in addition to full-service capabilities improvement. For example, WuXi AppTec in 2019 acquired Pharmapace. Furthermore, mid-sized companies and smaller contract research organizations are focusing majorly on niche sectors besides providing their sponsors with a personalized approach. Multiple companies are currently engaging in research and developmental activities for new drugs hence, outsourcing the activities to launch efficient CRO services in the market. This indirectly provides a constructive atmosphere for the market players to engage in joint ventures owing to the preference of the sponsors to maximize their benefits.

The preclinical CRO services’ strict regulatory policies are a major drawback to the overall growth of the market. However, the process of drug approval over the years has been significantly changed and modified by the Food and Drug Administration (FDA). Recently in the U.S., the 21st Century Cures bill was passed to quicken the approval process for the launch of breakthrough drugs and medical devices. These changes in approval processes are anticipated to drive market growth with innovation and increase demand for preclinical services.

Preclinical CRO Market Report Key Takeaways

  • In 2021 the toxicology segment registered the largest share of more than 25.48% owing to its significance in Investigational New Drug (IND)-enabling studies
  • Owing to its high detection accuracy the Patient Derived Organoid (PDO) Model Segment accounted for the largest share in 2021 at 80.47%
  • The market of Asia Pacific is expected to expand at a CAGR of 10.9% making it to be the fastest growing region in the forthcoming years
  • The government and academic institutes segment is projected to register the fastest CAGR of 8.2% during the forecasted year owing to the rising government initiatives for the healthcare sectors in the developing economies
  • In 2021, North America held the highest revenue share due to the huge investments in healthcare R&D with highly developed healthcare infrastructure


Preclinical CRO Market Segments

  • Preclinical CRO Service Outlook (Revenue, USD Million, 2018 - 2030)
    • Bioanalysis and DMPK studies
      • In vitro ADME
      • In-vivo PK
    • Toxicology Testing
      • GLP
      • Non-GLP
    • Compound Management
      • Process R&D
      • Custom Synthesis
      • Others
    • Chemistry
      • Medicinal Chemistry
      • Computation Chemistry
    • Safety Pharmacology
    • Others
  • Preclinical CRO Model Type Outlook (Revenue, USD Million, 2018 - 2030)
    • Patient Derived Organoid (PDO) Model
    • Patient derived xenograft model
  • Preclinical CRO End-use Outlook (Revenue, USD Million, 2018 - 2030)
    • Biopharmaceutical Companies
    • Government and Academic Institutes
    • Medical Device Companies
  • Preclinical CRO Regional Outlook (Revenue, USD Million, 2018- 2030)
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • South Korea
    • Latin America
      • Brazil
      • Mexico
      • Argentina
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
  • List of Key Players in the Preclinical CRO Market
    • Eurofins Scientific
    • PRA Health Sciences, Inc.
    • Wuxi AppTec
    • Medpace, Inc.
    • Charles River Laboratories International, Inc.
    • Pharmaceutical Product Development (PPD), LLC
    • SGS SA (SGS)
    • Intertek Group Plc (IGP)
    • Laboratory Corporation of America, Inc.
    • Crown Bioscience
What questions do you have? Get quick response from our industry experts. Request More information
Key questions answered in the report include
key questions
We also offers customization on reports based on specific client requirement.
Request for Customization

Choose License Type

Research Assistance

Ryan Manuel
Ryan Manuel

Research Support Specialist, USA

  1. Phone: +1-408-610-2300
  2. Toll Free: +1-866-831-4085
  3. Email: [email protected]
Connect With Expert
  • World's largest premium report database
  • Transparent pre & post sale customer engagement model
  • Unparalleled flexibility in terms of rendering services
  • Safe & secure web experience
  • 24*5 Research support service

Get a Free Sample

FREE sample contains market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...